About
Cancer drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalAustralia
Team (15)
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
261
By Phase
PHASE2: 1PHASE1: 3PHASE1/PHASE2: 3
By Status
COMPLETED: 4TERMINATED: 2RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06854653Lead Sponsor
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
PHASE2Recruiting
115 participants
Started: Mar 28, 2025 · Completed: Jun 30, 2028
NCT03900442Lead Sponsor
Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
PHASE1Completed
25 participants
Started: Sep 1, 2019 · Completed: Aug 8, 2025
NCT02930109Lead Sponsor
A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia
PHASE1/PHASE2Completed
33 participants
Started: Dec 9, 2016 · Completed: Mar 4, 2024
NCT01690468Lead Sponsor
PTX-200 and Carboplatin in Ovarian Cancer
PHASE1/PHASE2Terminated
15 participants
Started: Sep 30, 2014 · Completed: Dec 31, 2019
NCT01697293Lead Sponsor
PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer
PHASE1/PHASE2Terminated
34 participants
Started: Jan 31, 2012 · Completed: Jun 30, 2020
Locations (1)
Headquarters
South Melbourne, Australia
Map
Loading map...